Sputnik International


MOSCOW (Sputnik) - Russia's State Research Centre of Virology and Biotechnology Vector will complete the clinical trials of its vaccine against COVID-19 on 30 September, Anna Popova, the head of the Rospotrebnadzor public health watchdog, said on Monday.

"Our colleagues are focusing on one vaccine, the peptide vaccine, its clinical trials are now being completed. 30 September is the final date", Popova said at the All-Russian Congress on Infectious Diseases.
Clinical trials of Russia’s second coronavirus vaccine is set to be concluded in late September, Deputy Prime Minister Tatyana Golikova said in August, adding that no complications among the volunteers have been registered. If successful, the vaccine will carry the name EpiVacCorona.

World's First COVID-19 Vaccine ©
Photo : RDIF and Gamaleya Research Centre
Questions on Russia’s Sputnik V Vaccine Answered, Time for Critics to Look for Plank in Own Eyes

The press service of the Russian consumer health watchdog previously said that all volunteers for the Stage 1 of clinical trials for the COVID-19 vaccine of Russian research center Vektor have developed antibodies.
Earlier in August, Russian President Vladimir Putin announced the registration of the world’s first vaccine against the virus that causes COVID-19, which was developed by the Russian Gamaleya Research Institute.

Community standardsDiscussion

  • Сomment
  • avatar

    Add Comment

    Thank you! Your comment will be reviewed by the moderator for compliance with the Rules

    Add more

  • Post limit reached. Please try again in a minute.

  • Your comment contains a link, so it can't be published on our site

All comments
Show more comments (20)

    Show new comments (0)

    • Сomment
    • Reply


      in reply to(Show commentHide comment)

      | Edit | Delete


    Thank you! Your comment will be reviewed by the moderator for compliance with the RulesSource: